Premium Tax Credits in the American Rescue Plan and Off-Marketplace Enrollees
We estimate that the median 2021 premium tax credit for off-marketplace enrollees in California would be $311 if they switched to marketplace plans, with wide variation by age and plan size.
Delivery System Performance as Financial Risk Varies
One delivery system’s healthcare utilization in its Medicare Advantage product was notably less than in its Pioneer accountable care organization or in a traditional Medicare comparison group.
The Introduction of Generic Risperidone in Medicare Part D
This study examines the plan characteristics associated with generic risperidone use and spending and adherence outcomes associated with use among Medicare Advantage Part D beneficiaries.
A Comparison of Relative Resource Use and Quality in Medicare Advantage Health Plans Versus Traditional Medicare
Compared with traditional Medicare, relative resource use for those with diabetes or cardiovascular disease is lower in Medicare Advantage, while quality of care is higher.
Drug Plan Design Incentives Among Medicare Prescription Drug Plans
Medicare-Advantage Prescription drug plans (MA-PDs) and standalone PDPs appear to respond to different incentives for plan design.
Using Medicare Data for Comparative Effectiveness Research: Opportunities and Challenges
This review article explores the Medicare data available for researchers and approaches that could be used to enhance the data%u2019s value for comparative effectiveness research.
The Structure of Risk Adjustment for Private Plans in Medicare
Health plan accounting data are used to test how well the CMSHCC risk adjustment system tracks relative costs of treating various diagnoses: not very well.
Geographic Correlation Between Large-Firm Commercial Spending and Medicare Spending
Traditional Medicare and the large-firm commercial sector have a positive correlation in hospital utilization, but a lack of correlation in spending.
Utilization Outcomes and Patient Cost Sharing
What Does the RAND Health Insurance Experiment Tell Us About the Impact of Patient Cost Sharing on Health Outcomes?
Value-based insurance design may reduce the adverse consequences of cost sharing, as well as support quality improvement initiatives.
Incentive Formularies and Changes in Prescription Drug Spending
